Discovery of a new class of 16-membered (2Z,11Z)-3,11-di(aryl/naphthyl)-1,13-dioxa-5,9-dithia-2,12-diazacyclohexadeca-2,11-dienes as anti-tumor agents
作者:Mohan Reddy Bodireddy、Ranjeet Singh Mahla、P. Md. Khaja Mohinuddin、G. Trivikram Reddy、D. Vijaya Raghava Prasad、Himanshu Kumar、N. C. Gangi Reddy
DOI:10.1039/c6ra15140j
日期:——
small macrocyclic compounds, (2Z,11Z)-3,11-di(aryl/naphthyl)-1,13-dioxa-5,9-dithia-2,12-diazacyclohexadeca-2,11-dienes (1a–k) were designed and developed by a simple and practical synthetic route from readily available substrates using simple organic transformations. Evaluation of in vitro anti-tumor activities on human triple negative breast cancer cells MDAMB-231 cell lines reveal that the macrocycles
一系列新的16元小环化合物(2 Z,11 Z)-3,11-二(芳基/萘基)-1,13-二氧杂-5,9-二硫杂-2,12-二氮杂环十六烷2, 11-二烯(1a-k)是通过简单易行的合成路线,通过简单的有机转化,从容易获得的底物上设计和开发的。对人三阴性乳腺癌细胞MDAMB-231细胞系的体外抗肿瘤活性的评估表明,大环1a,1f,1g,1i和1k抑制细胞迁移和增殖,上调抗肿瘤基因p53,MDA7和TRAIL证明了它们是有前途的抗肿瘤化合物。大环化合物的抗增殖作用对癌细胞具有特异性,但未观察到对正常乳腺上皮细胞的细胞毒性作用(MCF10A)。发达的合成路线不含金属,保护基团和无空气技术。通过单晶XRD研究证实了大环(1e)的结构。